Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Genes show the way to better treatment of hepatitis A


One of the most common causes of hepatitis A (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not all patients are cured by the treatment currently available. New research shows that the response to medical treatment depends on genetic factors.

Our best defence against viral infections is the immune system. However, humans are endowed differently in terms of our immune defence. Recent research has shown how our genetic make-up heavily influences our ability to combat viral infections. Surprisingly, it now turns out that some of the genes that are good for the immune system can at the same time impede medical treatment.

Hepatitis C virus (HCV) infection causes chronic inflammation of the liver, which is slowly broken down and in some cases the disease can progress to liver cancer. It is possible to treat the disease with antiviral medicine, but patients react differently to the treatment and not all of them recover.

An international research group led by scientists at Aarhus University, Denmark, has now found out why some patients respond to the treatment, while others do not. The result of the treatment is determined to a very great extent by the individual patient's genetic heritage (genome). To the great surprise of the researchers, it turns out that variations in our genes for the interferon lambda 4 protein (IFNL4) determine whether we respond well or poorly to treatment.

"Our research shows that genetic mutations that reduce the activity of the interferon lambda 4 protein provide patients with a considerably better chance of recovering from the infection. Or to put it another way, a functional interferon lambda 4 protein is harmful during an infection with HCV. This is paradoxical because IFNL4 is an essential part of our immune defence against viral infections, and should therefore have a positive effect," says Associate Professor Rune Hartmann, Department of Molecular Biology and Genetics, Aarhus University.

Paradox in the laboratory

IFNL4 is a member of the family of proteins called interferons (named after their ability to interfere with viruses), which are an essential part of our immune defence against viral infections. They work by activating a cellular programme that combats viral infections and thereby makes the cells resistant to the virus.

The research group's studies show that IFNL4 has a powerful antiviral activity in the laboratory, and behaves in every way like any other member of the interferon family. Even though IFNL4 is antiviral in the laboratory, the research also clearly shows that it has the opposite effect in patients. This is where the paradox arises. The researchers have a possible explanation of why this happens.

"Our hypothesis is that interferon lambda 4 confuses other parts of the immune system and that HCV is able to exploit this," says PhD student Ewa Terczynska-Dyla, who also took part in the research project.

Possibility of better treatment

The research results from Aarhus University indicate that it is possible to develop new treatments for hepatitis that match the individual patient's genome. This could be medicine specifically targeting IFNL4, but could also include modifying the normal treatment, depending on whether the patients have fully functional IFNL4 genes, or have a version with either reduced activity or no activity at all.

The latter group of patients is by far the biggest in Denmark, and they do not require anywhere near as long a period of treatment to recover. This is good for both the patients (because they avoid unnecessary treatment) and the public medical expenses (because HCV medicine is very expensive).

The researchers will now carry out further work to understand the fundamental mechanisms that make the interferon lambda genes so important for our ability to combat hepatitis caused by HCV.

The results will be published in the journal Nature Communications 23 December 2014.

For more information, please contact

Associate Professor Rune Hartmann
Department of Molecular Biology and Genetics
Aarhus University, Denmark
+45 2899 2578

PhD student Ewa Terczynska-Dyla
Department of Molecular Biology and Genetics
Aarhus University, Denmark
+45 8715 6638

Rune Hartmann | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>